Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

New methods for skin and nerve regeneration can improve healing and feeling after burns.

Hair follicles help guide nerve growth, improving touch recovery in skin grafts.

More research is needed to find effective treatments for hair loss caused by valproic acid.

New treatments for male hypogonadism are easier to use and target specific tissues to reduce side effects.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Short-acting testosterone injections in a clinic are a preferred treatment for low testosterone because they work well, are convenient, and patients stick with the treatment.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

The treatment successfully lowered testosterone levels and reduced symptoms.

A new model helps predict treatment success in girls with early puberty.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Dienogest is safer and has fewer side effects than GnRH analogues for treating endometriosis.

The therapies improved ejaculation disorders and sexual function in middle-aged men.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Testosterone pellets might work for transgender men's hormone therapy, but more research is needed.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

PRP injections did not significantly improve ovarian function in women with low ovarian reserve.